Healthcare · Industry
Biotechnology - List & Prices (608 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| enGene Therapeutics Inc. | ENGN | $1.63 | $109.24M | — | |
| Cibus, Inc. | CBUS | $1.41 | $107.00M | — | |
| Unicycive Therapeutics, Inc. | UNCY | $3.87 | $106.01M | — | |
| Vivani Medical, Inc. | VANI | $1.16 | $104.64M | — | |
| PolyPid Ltd. | PYPD | $5.07 | $102.98M | — | |
| PMV Pharmaceuticals, Inc. | PMVP | $1.36 | $102.70M | — | |
| Immunic, Inc. | IMUX | $7.48 | $102.06M | — | |
| LENZ Therapeutics, Inc. | LENZ | $3.22 | $101.17M | — | |
| NeurAxis, Inc. | NRXS | $7.92 | $99.46M | — | |
| Coya Therapeutics, Inc. | COYA | $4.14 | $97.12M | — | |
| Polaryx Therapeutics, Inc. | PLYX | $1.94 | $96.70M | — | |
| Aardvark Therapeutics, Inc. | AARD | $4.41 | $96.51M | — | |
| ImmuCell Corporation | ICCC | $10.52 | $95.54M | 150.3 | — |
| Anixa Biosciences, Inc. | ANIX | $2.71 | $94.21M | — | |
| Atara Biotherapeutics, Inc. | ATRA | $9.35 | $93.85M | — | |
| Genelux Corporation | GNLX | $2.07 | $93.66M | — | |
| Kazia Therapeutics Limited | KZIA | $8.18 | $93.47M | — | |
| OnKure Therapeutics, Inc. | OKUR | $2.30 | $93.14M | — | |
| Tonix Pharmaceuticals Holding Corp. | TNXP | $5.43 | $93.13M | — | |
| Equillium, Inc. | EQ | $1.42 | $90.04M | — | |
| PDS Biotechnology Corporation | PDSB | $1.24 | $89.87M | — | |
| Tenaya Therapeutics, Inc. | TNYA | $0.39 | $87.49M | — | |
| Milestone Pharmaceuticals Inc. | MIST | $0.70 | $86.56M | — | |
| Rallybio Corporation | RLYB | $16.22 | $86.17M | 2.0 | — |
| Rani Therapeutics Holdings, Inc. | RANI | $0.61 | $85.01M | — | |
| Conexeu Sciences Inc. | CNXU | $3.33 | $84.34M | — | |
| NeOnc Technologies Holdings, Inc. | NTHI | $2.90 | $83.54M | — | |
| Corbus Pharmaceuticals Holdings, Inc. | CRBP | $4.29 | $82.88M | — | |
| Inovio Pharmaceuticals, Inc. | INO | $0.80 | $82.23M | — | |
| ProMIS Neurosciences, Inc. | PMN | $9.13 | $81.88M | — | |
| OKYO Pharma Limited | OKYO | $1.54 | $80.82M | — | |
| Acrivon Therapeutics, Inc. | ACRV | $1.83 | $78.21M | — | |
| Neumora Therapeutics, Inc. | NMRA | $0.42 | $78.16M | — | |
| Cognition Therapeutics, Inc. | CGTX | $0.75 | $76.24M | — | |
| Telomir Pharmaceuticals, Inc. | TELO | $1.02 | $75.09M | — | |
| Helix BioPharma Corp. | HBP.TO | CA$0.98 | CA$74.85M | — | |
| Nutriband Inc. | NTRB | $6.14 | $74.64M | — | |
| Cardiff Oncology, Inc. | CRDF | $0.94 | $73.05M | — | |
| Pelthos Therapeutics Inc. | PTHS | $18.70 | $71.59M | — | |
| MAIA Biotechnology, Inc. | MAIA | $1.14 | $70.39M | — | |
| MediciNova, Inc. | MNOV | $1.41 | $69.40M | — | |
| Cingulate Inc. | CING | $4.66 | $68.64M | — | |
| Spero Therapeutics, Inc. Common Stock | SPRO | $1.17 | $68.13M | 8.4 | — |
| Champions Oncology, Inc. | CSBR | $4.85 | $67.51M | — | |
| Oncolytics Biotech Inc. | ONCY | $0.51 | $67.06M | — | |
| Fortress Biotech, Inc. | FBIO | $1.94 | $64.70M | 0.7 | — |
| Heron Therapeutics, Inc. | HRTX | $0.34 | $64.32M | — | |
| Apollomics, Inc. | APLM | $21.59 | $62.94M | — | |
| Verrica Pharmaceuticals Inc. | VRCA | $3.63 | $62.36M | — | |
| Tenax Therapeutics, Inc. | TENX | $1.63 | $61.00M | — |
enGene Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $109.24M
- P/E
- unprofitable
Cibus, Inc.
Healthcare / Biotechnology
- Market Cap
- $107.00M
- P/E
- unprofitable
Unicycive Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $106.01M
- P/E
- unprofitable
Vivani Medical, Inc.
Healthcare / Biotechnology
- Market Cap
- $104.64M
- P/E
- unprofitable
PolyPid Ltd.
Healthcare / Biotechnology
- Market Cap
- $102.98M
- P/E
- unprofitable
PMV Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $102.70M
- P/E
- unprofitable
Immunic, Inc.
Healthcare / Biotechnology
- Market Cap
- $102.06M
- P/E
- unprofitable
LENZ Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $101.17M
- P/E
- unprofitable
NeurAxis, Inc.
Healthcare / Biotechnology
- Market Cap
- $99.46M
- P/E
- unprofitable
Coya Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $97.12M
- P/E
- unprofitable
Polaryx Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $96.70M
- P/E
- unprofitable
Aardvark Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $96.51M
- P/E
- unprofitable
ImmuCell Corporation
Healthcare / Biotechnology
- Market Cap
- $95.54M
- P/E
- 150.3
Anixa Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $94.21M
- P/E
- unprofitable
Atara Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $93.85M
- P/E
- unprofitable
Genelux Corporation
Healthcare / Biotechnology
- Market Cap
- $93.66M
- P/E
- unprofitable
Kazia Therapeutics Limited
Healthcare / Biotechnology
- Market Cap
- $93.47M
- P/E
- unprofitable
OnKure Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $93.14M
- P/E
- unprofitable
Tonix Pharmaceuticals Holding Corp.
Healthcare / Biotechnology
- Market Cap
- $93.13M
- P/E
- unprofitable
Equillium, Inc.
Healthcare / Biotechnology
- Market Cap
- $90.04M
- P/E
- unprofitable
PDS Biotechnology Corporation
Healthcare / Biotechnology
- Market Cap
- $89.87M
- P/E
- unprofitable
Tenaya Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $87.49M
- P/E
- unprofitable
Milestone Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $86.56M
- P/E
- unprofitable
Rallybio Corporation
Healthcare / Biotechnology
- Market Cap
- $86.17M
- P/E
- 2.0
Rani Therapeutics Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $85.01M
- P/E
- unprofitable
Conexeu Sciences Inc.
Healthcare / Biotechnology
- Market Cap
- $84.34M
- P/E
- unprofitable
NeOnc Technologies Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $83.54M
- P/E
- unprofitable
Corbus Pharmaceuticals Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $82.88M
- P/E
- unprofitable
Inovio Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $82.23M
- P/E
- unprofitable
ProMIS Neurosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $81.88M
- P/E
- unprofitable
OKYO Pharma Limited
Healthcare / Biotechnology
- Market Cap
- $80.82M
- P/E
- unprofitable
Acrivon Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $78.21M
- P/E
- unprofitable
Neumora Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $78.16M
- P/E
- unprofitable
Cognition Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $76.24M
- P/E
- unprofitable
Telomir Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $75.09M
- P/E
- unprofitable
Helix BioPharma Corp.
Healthcare / Biotechnology
- Market Cap
- CA$74.85M
- P/E
- unprofitable
Nutriband Inc.
Healthcare / Biotechnology
- Market Cap
- $74.64M
- P/E
- unprofitable
Cardiff Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $73.05M
- P/E
- unprofitable
Pelthos Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $71.59M
- P/E
- unprofitable
MAIA Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $70.39M
- P/E
- unprofitable
MediciNova, Inc.
Healthcare / Biotechnology
- Market Cap
- $69.40M
- P/E
- unprofitable
Cingulate Inc.
Healthcare / Biotechnology
- Market Cap
- $68.64M
- P/E
- unprofitable
Spero Therapeutics, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $68.13M
- P/E
- 8.4
Champions Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $67.51M
- P/E
- unprofitable
Oncolytics Biotech Inc.
Healthcare / Biotechnology
- Market Cap
- $67.06M
- P/E
- unprofitable
Fortress Biotech, Inc.
Healthcare / Biotechnology
- Market Cap
- $64.70M
- P/E
- 0.7
Heron Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $64.32M
- P/E
- unprofitable
Apollomics, Inc.
Healthcare / Biotechnology
- Market Cap
- $62.94M
- P/E
- unprofitable
Verrica Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $62.36M
- P/E
- unprofitable
Tenax Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $61.00M
- P/E
- unprofitable
Showing 351–400 of 608 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.